Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Sjogren's Syndrome

• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
• A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
• A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
• Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome
• Nasal Spray Study in Sjogren's Dry Eye Disease
• Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
• Tacrolimus for Thrombocytopenia in SS
• A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
• Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome
• ADX-629 Therapy for Sjogren-Larsson Syndrome
• Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
• Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome
• An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)
• New Clinical End-points in Patients With Primary Sjögren's Syndrome
• Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
• Efficacy and Safety of Baricitinib in Sjogren's Syndrome
• Fish Oil (Omega 3 ) in Sjogren's Syndrome
• A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
• The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
• A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients
• Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
• CEQUA for Sjogren's Syndrome Dry Eye
• A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
• Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
• N-acetylcysteine for Primary Sjögren's Syndrome
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome
• Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients
• Effect of Ciclosporin Eyedrops on Sjögren Syndrome
• Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
• BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome
• Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
• Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
• Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants
• A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
• A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.
• Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
• A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
• Levocarnitine for Dry Eye in Sjogren's Syndrome
• Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
• Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome
• Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
• Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome
• A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
• Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies
• A Study of INCB050465 in Primary Sjögren's Syndrome
• Comparison Between Rebamipide 2% Versus Autologous Serum
• Quality of Life and Sjögren Syndrome
• RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
• Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
• Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction
• Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
• A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)
• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome
• Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
• Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
• Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
• Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
• A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
• Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome
• Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
• A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
• UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
• A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
• A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
• A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
• Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
• Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax
• Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
• Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
• PD of VAY736 in Patients With Primary Sjögren's Syndrome
• Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
• Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
• Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
• Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
• Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
• Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
• Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
• Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
• Rebamipide AND Sjögren Syndrome
• Omalizumab for Lupus
• Low Dose Cyclosporin A in Primary Sjögren Syndrome
• Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
• Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
• An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
• Pulmozyme for Sjogren's Associated Cough
• Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
• Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
• Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
• Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients
• A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
• Tolerance and Efficacy of Rituximab in Sjogren's Disease
• Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome
• Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
• Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
• Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention
• Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
• Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
• A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment
• Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
• Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
• Rituximab Treatment in Sjogren's Syndrome
• Pilot Study of Raptiva to Treat Sjogren's Syndrome
• Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
• Anti-CD20 Antibody Therapy for Sjogren's Syndrome
• Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
• Etanercept Therapy for Sjogren's Syndrome
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
• Pilot Study of Thalidomide to Treat Sjogren's Syndrome
• DHEA Treatment for Sjogren's Syndrome